COVID-19 Vaccination Engagement and Barriers among Mississippi Pharmacists
Open Access
Abstract
After the emergency use authorization of coronavirus disease 2019 (COVID-19) vaccinations in the United States, existing pharmacy infrastructure was leveraged to disseminate vaccines. However, the national uptake of COVID-19 vaccines remains poor. This survey study of Mississippi pharmacists aimed to identify barriers to providing COVID-19 vaccination among pharmacists in practice settings that provided other vaccines. A thematic analysis was used to analyze open-ended survey responses. This study found that the greatest identified barrier to COVID-19 vaccination for pharmacists was patient willingness. The thematic analysis revealed logistical barriers, vaccine hesitancy, and rural pharmacy distribution concerns. These findings suggest that pharmacists require further training in overcoming vaccine hesitancy, and potentially indicate a need for the distribution of vaccination responsibilities to additional pharmacy staff members.Keywords
This publication has 5 references indexed in Scilit:
- Understanding COVID-19 vaccine hesitancyNature Medicine, 2021
- Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deploymentThe Lancet, 2021
- Beyond confidence: Development of a measure assessing the 5C psychological antecedents of vaccinationPLOS ONE, 2018
- Beyond confidence: Development of a measure assessing the 5C psychological antecedents of vaccinationPsyArXiv, 2018
- Vaccine hesitancy: Definition, scope and determinantsVaccine, 2015